Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas.
Zohar
Sarah
S
INSERM, Biostatistics Department, Paris, France.
Baldi
Ileana
I
Forni
Guido
G
Merletti
Franco
F
Masucci
Giuseppe
G
Gregori
Dario
D